Molecular pathogenesis of adenoma and differentiated adenocarcinoma of the stomach

Pathology International

Volumn 46, Issue 11, 1996, Pages 834-841

  Tamura, Gen ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

gastric adenocarcinoma; gastric adenoma; loss of heterozygosity; mutation; tumor suppressor gene

Indexed keywords

PROTEIN P53;

ADENOMA; ADENOMATOUS POLYP; COLON CARCINOGENESIS; COLORECTAL CARCINOMA; GENE DELETION; GENE MUTATION; HUMAN; MALIGNANT TRANSFORMATION; ONCOGENE K RAS; PRIORITY JOURNAL; REVIEW; STOMACH ADENOCARCINOMA; TUMOR SUPPRESSOR GENE;

EID: 0029906627     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.1996.tb03556.x     Document Type: Review

References (69)

1. Powell SM, Zilz N, Beazer-Barclay et al. APC mutations occur early during colorectal tumorigenesis. Nature 1992; 359: 235-237.
2. Vogelstein B, Fearon ER, Hamilton SR et al. Genetic alterations during colorectal-tumor development. N. Engl. J. Med. 1988; 319: 525-532.
3. Baker SJ, Preisinger AC, Jessup JM et al. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res. 1990; 50: 7717-7722.
4. Kikuchi-Yanoshita R, Konishi M, Fukunari H, Tanaka K, Miyaki M. Loss of expression of the DCC gene during progression of colorectal carcinomas in familial adenomatous polyposis and non-familial adenomatous polyposis patients. Cancer Res. 1992; 52: 3801-3803.
5. Tahara E. Molecular mechanism of stomach carcinogenesis. J. Cancer Res. Clin. Oncol. 1993; 119: 265-272.
6. Uchino S, Noguchi M, Ochiai A, Saito T, Kobayashi M, Hirohashi S. p53 mutation in gastric cancer: A genetic model for carcinogenesis is common to gastric and colorectal cancer. Int. J. Cancer 1993; 54: 759-764.
7. Joslyn G, Carlson M, Thliveris A et al. Identification of deletion mutations and three new genes at the familial polyposis locus. Cell 1991; 66: 601-613.
8. Kinzler KW, Nilbert MC, Su L-K et al. Identification of FAP locus genes from chromosome 5q21 that is mutated in colorectal cancers. Science 1991; 253: 661-665.
9. Groden J, Thliveris A, Samowitz W et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991; 66: 589-600.
10. Rubinfeld B, Souza B, Albert I et al. Association of the APC gene product with β-catenin. Science 1993; 262: 1731-1734.
11. Su L-K, Vogelstein B, Kinzler KW. Association of the APC tumor suppressor protein with catenins. Science 1993; 262: 1734-1737.
12. Miyoshi Y, Ando H, Nagase H et al. Germ-line mutations of the APC gene in 53 familial adenomatous polyposis patients. Proc. Natl Acad. Sci. USA 1992; 89: 4452-4456.
13. Miyoshi Y, Nagase H, Ando H et al. Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum. Mol. Genet. 1992; 1: 229-233.
14. Uzawa K, Yoshida H, Suzuki H et al. Abnormalities of the adenomatous polyposis coli gene in human oral squamous-cell carcinoma. Int. J. Cancer 1994; 58: 814-817.
15. Kashiwaba M, Tamura G, Ishida M. Aberrations of the APC gene in primary breast carcinoma. J. Cancer Res. Clin. Oncol. 1994; 120: 727-731.
16. Powell SM, Papadopoulous N, Kinzler KW, Smolinski KN, Meltzer SJ. APC gene mutations in the mutation cluster region are rare in esophageal cancers. Gastroenterology 1994; 107: 1759-1763.
17. Horii A, Nakatsuru S, Miyoshi Y et al. Frequent somatic mutations of the APC gene in human pancreatic cancer. Cancer Res. 1992; 52: 6696-6698.
18. Horii A, Nakatsuru S, Miyoshi T et al. The APC gene, responsible for familial adenomatous polyposis, is mutated in human gastric cancer. Cancer Res. 1992; 52: 3231-3233.
19. Nakatsuru S, Yanagisawa A, Ichii S et al. Somatic mutations of the APC gene in gastric cancer: Frequent mutations in very well differentiated adenocarcinoma and signet-ring cell carcinoma. Hum. Mol. Genet. 1992; 1: 559-563.
20. Tamura G, Maesawa C, Suzuki Y et al. Mutations of the APC gene occur during early stages of gastric adenoma development. Cancer Res. 1994; 54: 1149-1151.
21. Nakatsuru S, Yanagisawa S, Furukawa Y et al. Somatic mutations of the APC gene in precancerous lesion of the stomach. Hum. Mol. Genet. 1993; 2: 1463-1465.
22. Nishimura K, Yokozaki H, Haruma K, Kajiyama G, Tahara E. Alterations of the APC gene in carcinoma cell lines and precancerous lesions of the stomach. Int. J. Oncol. 1995; 7: 587-592.
23. Ogasawara S, Maesawa C, Tamura G, Satodate R. Lack of mutations of the adenomatous polyposis coli gene in oesophageal and gastric carcinomas. Virchows Arch. 1994; 424: 607-611.
24. Maesawa C, Tamura G, Suzuki Y et al. The sequential accumulation of genetic alterations characteristic of the colorectal adenoma-carcinoma sequence does not occur between gastric adenoma and adenocarcinoma. J. Pathol. 1995; 176: 249-258.
25. Koshiba M, Ogawa O, Habuchi T et al. Infrequent ras mutation in human stomach cancers. Jpn. J. Cancer Res. 1993; 84: 163-167.
26. Sakurai S, Sano T, Maeshima A et al. Gastric adenoma-carcinoma sequence with special reference to p53 and Ki-ras gene alterations. Virchows Arch. 1995; 427: 119-124.
27. Kihana T, Tsuda H, Hirota T et al. Point mutation of c-Ki-ras oncogene in gastric adenoma and adenocarcinoma with tubular differentiation. Jpn. J. Cancer Res. 1991; 82: 308-314.
28. Soh K, Yanagisawa A, Hiratsuka H, Sugano H, Kato Y. Variation in K-ras codon 12 mutation rate with histological atypia within individual colorectal tumors. Jpn. J. Cancer Res. 1993; 84: 388-393.
29. Tamura G, Sakata K, Maesawa C et al. Microsatellite alterations in adenoma and differentiated adenocarcinoma of the stomach. Cancer Res. 1995; 55: 1933-1936.
30. Tohdo H, Yokozaki H, Haruma K, Kajiyama G, Tahara E. p53 gene mutations in gastric adenomas. Virchows Arch. B Cell Pathol. 1993; 63: 191-195.
31. Tamura G, Kihana T, Nomura K, Tereda M, Sugimura T, Hirohashi S. Detection of frequent p53 gene mutations in primary gastric cancer by cell sorting and polymerase chain reaction single-strand conformation polymorphism analysis. Cancer Res. 1991; 51: 3056-3058.
32. Ssano H, Date F, Imatani A, Asaki S, Nagura H. Double immunostaining for c-erbB-2 and p53 in human stomach cancer cells. Hum. Pathol. 1993; 24: 584-589.
33. Uesugi H, Saegusa M, Takano Y, Okayasu I. Different expression of Bcl-2 protein in gastric adenomas and carcinomas. Pathol. Int. 1966; 46: 274-280.
34. Shiao Y-H, Rugge M, Correa P, Lehmann P, Scheer WD. p53 alteration in gastric precancerous lesions. Am. J. Pathol. 1994; 144: 511-517.
35. Rugge M, Farinati F, Mario FD, Baffa R, Valiante F, Cardin F. Gastric epithelial dysplasia: A prospective multicenter follow-up study from the interdisciplinary group on gastric epithelial dysplasia. Hum. Pathol. 1991; 22: 1002-1008.
36. Hedrick L, Cho KR, Fearon ER, Wu T-C, Kinzler KW, Vogelstein B. The DCC gene product in cellular differentiation and colorectal tumorigenesis. Genes Dev. 1994; 8: 1174-1183.
37. Ookawa K, Sakamoto M, Hirohashi S et al. Concordant p53 and DCC alterations and allelic losses on chromosomes 13q and 14q associated with liver metastases of colorectal carcinoma. Int. J. Cancer 1993; 53: 382-387.
38. Tamura G, Sakata K, Nishizuka S et al. Allelotype of adenoma and differentiated adenocarcinoma of the stomach. J. Pathol. (in press).
39. Uchino S, Tsuda H, Noguchi M et al. Frequent loss of heterozygosity at the DCC locus in gastric cancer. Cancer Res. 1992; 52: 3099-3102.
40. Fey MF, Hesketh C, Wainscoat JS, Gendler S, Thein SL. Clonal allele loss in gastrointestinal cancers. Br. J. Cancer 1989; 59: 750-754.
41. Sano T, Tsujino T, Yoshida K et al. Frequent loss of heterozygosity on chromosomes 1q, 5q, and 17p in human gastric carcinomas. Cancer Res. 1991; 51: 2926-2931.
42. Tamura G, Maesawa C, Suzuki Y et al. Primary gastric carcinoma cells frequently lose heterozygosity at the APC and MCC genetic loci. Jpn. J. Cancer Res. 1993; 84: 1015-1018.
43. McKie AB, Filipe MI, Lemoine NR. Abnormalities affecting the APC and MCC tumour suppressor gene loci on chromosome 5q occur frequently in gastric cancer but not in pancreatic cancer. Int. J. Cancer 1993; 55: 598-603.
44. Kuniyasu H, Yasui W, Yokozaki H et al. Frequent loss of heterozygosity on the long arm of chromosome 7 is associated with progression of human gastric carcinomas. Int. J. Cancer 1994; 59: 597-600.
45. Baffa R, Negrini M, Mandes B et al. Loss of heterozygosity for chromosome 11 in adenocarcinoma of the stomach. Cancer Res. 1996; 56: 268-272.
46. Mori T, Yanagisawa A, Kato Y et al. Accumulation of genetic alterations during esophageal carcinogenesis. Hum. Mol. Genet. 1994; 3: 1969-1971.
47. Tamura G, Ogasawara S, Nishizuka S et al. Two distinct regions of deletion on the long arm of chromosome 5 in differentiated adenocarcinomas of the stomach. Cancer Res. 1966; 56: 612-615.
48. Harada H, Kitagawa M, Tanaka N et al. Anti-oncogenic and oncogenic potentials of Interferon regulatory factors-1 and -2. Science 1993; 259: 971-974.
49. El-Deiry WS, Tokino T, Velculescu VE et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993: 75: 817-825.
50. Shiohara M, El-Deiry WS, Wada M et al. Absence of WAF1 mutations in a variety of human malignancies. Blood 1994; 84: 3781-3784.
51. Watanabe H, Fukuchi K, Takagi Y, Tomoyasu S, Tsuruoka N, Gomi K. Molecular analysis of the Cip1/Waf1 (p21) gene in diverse types of human tumors. Biochim. Biophys. Acta 1995; 1263: 275-280.
52. Zenklusen JC, Bieche I, Lindereau R, Conti CJ. CA microsatellite repeat D7S522 is the most commonly deleted region in human primary breast cancer. Proc. Natl Acad. Sci. USA 1994; 91: 12 155-12 158.
53. Zenclusen JC, Thompson JC, Troncoso P, Kagan J, Conti CJ. Loss of heterozygosity in human primary prostate carcinomas: A possible tumor suppressor gene at 7q31.1. Cancer Res. 1994: 54: 6370-6373.
54. Zenclusen JC, Thompson JC, Klein-Szanto AJP, Conti CJ. Frequent loss of heterozygosity in human primary squamous and colon carcinomas at 7q31.1: Evidence for a broad range tumor suppressor gene. Cancer Res. 55:1347-1350.
55. Negrini M, Rasio D, Hampton GM et al. Definition and refinement of chromosome 11 regions of loss of heterozygosity in breast cancer: Identification of a new region at 11 q23.3. Cancer Res. 1995; 55: 3003-3007.
56. Hampton GM, Penny LA, Baergen RN et al. Loss of heterozygosity in cervical carcinoma: Subchromosomal localization of a putative tumor suppressor gene to chromosome 11q22-q24. Proc. Natl Acad. Sci. USA 1994; 91: 6953-6957.
57. Gustafson CE, Young J, Legget B, Searle J, Chenevix-Trench G. Loss of heterozygosity on the long arm of chromosome 11 in colorectal tumors. Br. J. Cancer 1994; 70: 395-397.
58. Foulkes WD, Campbell IG, Stamp GWH, Trowsdale J. Loss of heterozygosity and amplification on chromosome 11 q in human ovarian cancer. Br. J. Cancer 1993; 67: 268-273.
59. Aaltonen LA, Peltomäki P, Leach FS et al. Clues to the pathogenesis of familial colorectal cancer. Science 1993; 260: 812-816.
60. Leach FS, Nicolaides NC, Papadopoulos N et al. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 1993; 75: 1215-1225.
61. Aaltonen LA, Peltomäki P, Mecklin J-P et al. Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients. Cancer Res. 1994; 54: 1645-1648.
62. Mao L, Lee DJ, Tockman MS, Erozan YS, Askin F, Sidransky D. Microsatellite alterations as clonal markers for the detection of human cancer. Proc. Natl Acad. Sci. USA 1994; 91: 9871-9875.
63. Loeb LA. Microsatellite instability: Marker of mutator phenotype in cancer. Cancer Res. 1994; 54: 5059-5063.
64. Han H-J,Yanagisawa A, Kato Y, Park J-G, Nakamura Y. Genetic instability in pancreatic cancer and poorly differentiated type of gastric cancer. Cancer Res. 1993; 53: 5087-5089.
65. Rhyu M-G, Park W-S, Meltzer SJ. Microsatellite instability occurs frequently in human gastric carcinoma. Oncogene 1994; 9: 29-32.
66. n DNA repeats and tumor suppressor genes in human gastric cancer. Cancer Res. 1994; 54: 41-44.
67. Chong J-M, Fukayama M, Hayashi Y et al. Microsatellite instability in the progression of gastric carcinoma. Cancer Res. 1994; 54: 4595-4597.
68. KamiyaT, MorishitaT, Asakura H, Miura S, Munakata Y, Tsuchiya M. Long-term follow-up study on gastric adenoma and its relation to gastric protruded carcinoma. Cancer 1982; 50: 2496-2503.
69. Nakamura K, Sakaguchi H, Enjoji M. Depressed adenoma of the stomach. Cancer 1988; 62: 2197-2202.